NCT03002246

Brief Summary

This trial is a collaborative study between 4 sites worldwide. A total of 600 research subjects will be enrolled. We will investigate the validity of using 5D Limb Volume software to improve on estimated fetal weight predictions over a broad range of gestational ages. The purpose is to compare the accuracy and precision of birth weight predictions based on this new technology as compared to the current 2D birth weight prediction models.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
330

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2017

Typical duration for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 21, 2016

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 23, 2016

Completed
14 days until next milestone

Study Start

First participant enrolled

January 6, 2017

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2019

Completed
Last Updated

July 23, 2019

Status Verified

July 1, 2019

Enrollment Period

2.1 years

First QC Date

December 21, 2016

Last Update Submit

July 22, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Comparison Between 5D Limb Vol and 2D Birth weight Prediction

    Compare the accuracy and precision of BW predictions based on 5D Limb Vol technology in pregnant women as compared to 2D BW prediction models

    Feb 2017 -Feb 2018

Secondary Outcomes (1)

  • Birth weight Predictions in Suspected Growth Abnormalities

    Feb 2017 - Feb 2018

Study Arms (3)

Average for Gestational Age

This cohort will include a sample size of 90 subjects. Fetuses will have an estimated fetal weight greater than 10th percentile and less than 90th percentile based on clinical ultrasound assessment. This cohort will receive an ultrasound examination 4-7 days before their delivery.

Other: Ultrasound Examination

Large for Gestational Age

This cohort will include a sample size of 30 subjects. Fetuses will have an estimated fetal weight greater than 90th percentile based on clinical ultrasound assessment.This cohort will receive an ultrasound examination 4-7 days before their delivery.

Other: Ultrasound Examination

Small for Gestational Age

This cohort will include a sample size of 30 subjects. Fetuses will have an estimated fetal weight less than 10th percentile based on clinical ultrasound assessment.This cohort will receive an ultrasound examination 4-7 days before their delivery.

Other: Ultrasound Examination

Interventions

Research volunteers will be invited to have a 2D/3D ultrasound research scan 4-7 days from delivery.This ultrasound scan will take approximately 30 minutes to complete.

Average for Gestational AgeLarge for Gestational AgeSmall for Gestational Age

Eligibility Criteria

Age18 Years - 64 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Pregnant women between 28-42 weeks gestation. Fetuses will be either small for gestational age (estimated fetal weight \< 10%), average for gestational age, or large for gestational age (estimated fetal weight \> 90%).

You may qualify if:

  • Pregnant women (28-42 weeks) within 4-7 days of delivery
  • Planned delivery at the collaborating hospital where the fetal US scan was performed
  • Body mass index at first official prenatal appointment below 35.0 kg/M2
  • Firm US dating criteria (early crown-rump length \< 14 weeks gestational age)

You may not qualify if:

  • Presence of technical factors (e.g. obesity) that make it difficult to visualize fetal structures
  • Oligohydramnios determined by amniotic fluid index less than 5cm
  • Fetal distress or unstable maternal condition
  • Structural or chromosomal fetal anomalies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Kang L, Wu QQ, Sun LJ, Gao FY, Wang JJ. Predicting fetal weight by three-dimensional limb volume ultrasound (AVol/TVol) and abdominal circumference. Chin Med J (Engl). 2021 Apr 20;134(9):1070-1078. doi: 10.1097/CM9.0000000000001413.

MeSH Terms

Conditions

Birth WeightFetal Growth RetardationFetal WeightFetal Macrosomia

Condition Hierarchy (Ancestors)

Body WeightSigns and SymptomsPathological Conditions, Signs and SymptomsFetal DiseasesPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesGrowth DisordersPathologic ProcessesDiabetes, GestationalPregnancy in DiabeticsDiabetes ComplicationsDiabetes MellitusEndocrine System Diseases

Study Officials

  • Wesley Lee, MD

    Baylor College of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. Wesley Lee

Study Record Dates

First Submitted

December 21, 2016

First Posted

December 23, 2016

Study Start

January 6, 2017

Primary Completion

January 31, 2019

Study Completion

January 31, 2019

Last Updated

July 23, 2019

Record last verified: 2019-07

Data Sharing

IPD Sharing
Will share